MMedication Read More All about new ‘triple-G’ drug that’s helped patients lose a quarter of their body weightApril 2, 2026 G whiz! The latest experimental GLP-1 from Eli Lilly isn’t just a diabetes drug — it also facilitates weight…
MMedication Read More GLP-1 RA generics have arrived. Could we buy semaglutide made for just $4?March 24, 2026 Semaglutide is now generic. Just not in Australia. But in China, Brazil and Canada, generic drug makers are…
NNutrition Read More Dr Michael Mosley says one meal time change could ‘reduce the risk of diabetes’March 23, 2026 Dr Michael Mosley, the pioneer behind intermittent fasting, says his dinner time change could also lower the chances…
MMedication Read More Ozempic Goes Generic —But Not in the USMarch 23, 2026 A drug that helped turn Novo Nordisk into Europe’s most valuable company is about to lose its…
MMedication Read More The Unexpected Mental Health Effect of GLP-1 MedicationsMarch 21, 2026 By now, you can probably list off the potential perks of going on a GLP-1 receptor agonist like…
HHealth Read More Semaglutide Falls Short in Alzheimer’s Phase 3 TrialsMarch 21, 2026 Phase 3 trials show oral semaglutide failed to slow early Alzheimer’s progression, potentially limiting its expansion beyond metabolic…
FFitness Read More ‘Early Bird’ Exercisers Get The Most Health Benefits, Study FindsMarch 20, 2026 “Early bird” exercise provides better health benefits for people, a new study says. People who regularly exercise in…
MMedication Read More Ozempic is getting generics as low as $15 — what it means for AmericansMarch 19, 2026 The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the…
HHealth Read More Weight-loss drugs may lower the risk of depression, anxiety, and self-harm, study findsMarch 19, 2026 Semaglutide, a common ingredient in GLP-1 weight-loss medications, is associated with lower risks of worsening mental disorders, according…
MMedication Read More Boston wants to limit GLP-1 drug coverage amid rising costsMarch 17, 2026 Ashley Groffenberger, the city’s chief financial officer, sent a letter to the City Council on Monday, saying health…
HHealth Read More New polygenic risk scores improve prediction of metabolic disease outcomesMarch 16, 2026 Type 2 diabetes (T2D) and obesity are metabolic conditions with many causes, including overlapping and distinct genetic features.…
MMedication Read More When will shots like Ozempic be covered by health insurance?March 12, 2026 GLP-1 drugs like Ozempic have long helped people eat less — now, they’re showing promise in helping people…